MetaCap

Neurogene Insider Trades

NASDAQ: NGNEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.40-0.10 (-0.38%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Pre-market: 26.80 +1.52%

Last 12 months

Purchases
0 · $0
Sales
17 · $1.13M
Shares bought / sold
0 / 41.58K
Net activity
Net selling $1.1 million

Neurogene insider activity

Over the last 12 months, Neurogene insiders reported 22 transactions on SEC Form 4: 0 open-market purchases and 17 sales. Insiders bought $0 and sold $1.1 million worth of stock, for net insider selling of $1.1 million. The largest seller was Cvijic Christine Mikail, with $900,023 in reported sales.

The most recent filing shows McMinn Rachel (Chief Executive Officer) reporting a transaction in 756 shares at $25.32 on Sep 22, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NGNE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NGNE insider transactions

Neurogene insider transactions
DateInsiderTypeSharesValueFiling
Sep 22, 2026McMinn RachelChief Executive OfficerOption exercise756$19.14KForm 4
Jul 7, 2026Cvijic Christine MikailPresident and CFOSale4,200$151.76KForm 4
Jul 6, 2026Cvijic Christine MikailPresident and CFOSale600$21.61KForm 4
Jul 2, 2026Cvijic Christine MikailPresident and CFOSale1,530$53.90KForm 4
Jul 2, 2026Cvijic Christine MikailPresident and CFOSale2,531$87.52KForm 4
Jul 1, 2026Cvijic Christine MikailPresident and CFOSale739$25.17KForm 4
May 6, 2026Cvijic Christine MikailPresident and CFOSale4,800$155.69KForm 4
May 6, 2026Cvijic Christine MikailPresident and CFOSale4,800$144.35KForm 4
Mar 26, 2026Jordan JulieChief Medical OfficerSale828$18.13KForm 4
Mar 26, 2026McMinn RachelChief Executive OfficerSale3,352$74.00KForm 4
Mar 26, 2026Cvijic Christine MikailPresident and CFOSale2,558$55.32KForm 4
Mar 13, 2026Cvijic Christine MikailPresident and CFOSale263$5.79KForm 4
Mar 13, 2026Cvijic Christine MikailPresident and CFOSale1,395$29.64KForm 4
Mar 13, 2026Cvijic Christine MikailPresident and CFOSale2,387$48.75KForm 4
Mar 13, 2026Cobb StuartChief Scientific OfficerSale148$3.27KForm 4
Mar 13, 2026Cobb StuartChief Scientific OfficerSale2,658$56.72KForm 4
Mar 13, 2026Cobb StuartChief Scientific OfficerSale3,991$81.46KForm 4
Feb 27, 2026Cvijic Christine MikailPresident and CFOSale4,800$120.53KForm 4
Feb 20, 2026McMinn RachelChief Executive OfficerAward25,900—Form 4
Feb 20, 2026Cobb StuartChief Scientific OfficerAward16,500—Form 4
Feb 20, 2026Cvijic Christine MikailPresident and CFOAward22,000—Form 4
Feb 20, 2026Jordan JulieChief Medical OfficerAward4,900—Form 4
May 14, 2025Cobb StuartChief Scientific OfficerSale6,797$103.00KForm 4
Mar 26, 2025Jordan JulieChief Medical OfficerAward8,400—Form 4
Mar 26, 2025Cvijic Christine MikailPresident and CFOAward20,300—Form 4
Mar 26, 2025McMinn RachelChief Executive OfficerAward23,900—Form 4
Mar 26, 2025Cobb StuartChief Scientific OfficerAward7,200—Form 4
Mar 13, 2025Cvijic Christine MikailPresident and CFOSale4,501$76.25KForm 4
Nov 26, 2024Samsara BioCapital GP, LLC & Samsara BioCapital, L.P. & AKKARAJU SRINIVAS10% OwnerBuy2,000$55.00KForm 4
Nov 26, 2024Samsara BioCapital GP, LLC & Samsara BioCapital, L.P. & AKKARAJU SRINIVAS10% OwnerBuy15,219$406.80KForm 4
Nov 26, 2024Samsara BioCapital GP, LLC & Samsara BioCapital, L.P. & AKKARAJU SRINIVAS10% OwnerBuy10,803$280.99KForm 4
Nov 26, 2024Samsara BioCapital GP, LLC & Samsara BioCapital, L.P. & AKKARAJU SRINIVAS10% OwnerBuy20,748$516.83KForm 4
Nov 22, 2024McMinn RachelChief Executive OfficerBuy47,500$969.00KForm 4
Nov 22, 2024Cvijic Christine MikailPresident and CFOBuy24,000$491.40KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related